Abstract:Negative elongation factor E (NELFE) has been demonstrated to promote cancer progression as an RNA-binding protein (RBP). However, the expression patterns, biological role and molecular mechanism of NELFE in pancreatic cancer (PC) remain largely unknown. The expression levels of NELFE in 120 pairs of PC tissues and adjacent non-tumor clinical samples collected from patients with PC were examined via reverse transcription-quantitative (RT-q) PCR and immunohistochemistry. The mRNA expression levels of NELFE, N-Myc downstream-regulated gene 2 (NDRG2), c-Myc, survivin and cyclin D1 were detected via RT-qPCR. The protein expression levels of NELFE, NDRG2, total beta-catenin, nuclear beta-catenin, cytosolic beta-catenin, E-cadherin, N-cadherin and Vimentin were measured by western blotting. NELFE and NDRG2 were then knocked-down by short hairpin (sh)RNA. PC cell proliferation was detected by MTT and colony formation assays. Invasion and migration were detected by transwell assays. The interaction between NELFE and NDRG2 was detected by luciferase reporter assays, mRNA decay assays and RNA immunoprecipitation. NELFE expression was increased in PC tissues compared with the paired non-cancerous tissues. NELFE expression was upregulated in PC cells when compared with normal pancreatic cells (HPDE6-C7). The present study revealed that knockdown of NELFE inhibited the proliferation, invasion and migration of PC cells. In addition, transfection of the sh-NELFE vector inhibited the epithelial-to-mesenchymal transition in PC cells by suppressing the expression and nuclear accumulation of beta-catenin. Further mechanistic studies revealed that NELFE activates the Wnt/beta-catenin signaling pathway by decreasing the stabilization of NDRG2 mRNA in PC. To the best of our knowledge, these results revealed the promotional function of NELFE on PC tumorigenesis and metastasis for the first time, helping to provide a promising strategy for the treatment of patients with PC.

NELF coordinates Pol II transcription termination and DNA replication initiation

NELF and PAF1C complexes are core transcriptional machineries controlling colon cancer stemness

NELF-mediated Stalling of Pol II Can Enhance Gene Expression by Blocking Promoter-Proximal Nucleosome Assembly.

NELF Regulates a Promoter-Proximal Step Distinct from RNA Pol II Pause-Release.

NELF focuses sites of initiation and maintains promoter architecture

Nek4 Regulates Entry into Replicative Senescence and the Response to DNA Damage in Human Fibroblasts.

ERK-mediated NELF-A phosphorylation promotes transcription elongation of immediate-early genes by releasing promoter-proximal pausing of RNA polymerase II

Overexpression of NELFCD Promotes Colorectal Cancer Cells Proliferation, Migration, and Invasion.

HNRNPLL stabilizes mRNA for DNA replication proteins and promotes cell cycle progression in colorectal cancer cells

Pause Patrol: Negative Elongation Factor's role in Promoter-Proximal Pausing and beyond

The Lncrna NEAT1 Inhibits Mirna-216B and Promotes Colorectal Cancer Progression by Indirectly Activating YY1

The Noncoding Function of NELFA Mrna Promotes the Development of Oesophageal Squamous Cell Carcinoma by Regulating the Rad17‐RFC2‐5 Complex

Dependency of NELF-E-SLUG-KAT2B Epigenetic Axis in Breast Cancer Carcinogenesis.

Small Nuclear Ribonucleoprotein Polypeptide N Accelerates Malignant Progression and Poor Prognosis in Colorectal Cancer Transcriptionally Regulated by E2F8

NELFE Promoted Pancreatic Cancer Metastasis and the Epithelial‑to‑mesenchymal Transition by Decreasing the Stabilization of NDRG2 Mrna.

Mutual dependency between lncRNA LETN and protein NPM1 in controlling the nucleolar structure and functions sustaining cell proliferation

Transcription Factor E2F7 Hampers the Killing Effect of NK Cells against Colorectal Cancer Cells via Activating RAD18 Transcription

Distinct negative elongation factor conformations regulate RNA polymerase II promoter-proximal pausing

NDF is a transcription factor that stimulates elongation by RNA polymerase II

NEIL1 drives the initiation of colorectal cancer through transcriptional regulation of COL17A1

Epithelial NELF Guards Intestinal Barrier Function to Ameliorate Colitis by Maintaining Junctional Integrity.